News
So I want to thank Tom Polen, Chairman and Chief Executive Officer of Becton, Dickinson. I appreciate you're making the time. I know you're on the -- you have a lot of different priorities right now.
11h
MarketBeat on MSNThese 3 Dividend Stocks Pay You to Stay Calm in SummerFor investors, summer is a time of lower volume and slower growth. Like the holiday season, this is a time when institutional ...
12h
Zacks Investment Research on MSNPfizer Stock Down Almost 11% YTD: Should You Buy the Dip?Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also ...
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology ...
Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
A new study finds a link between the use of antidiabetic drugs like SGLT2 inhibitors and a reduced risk for atrial ...
Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...
Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.
Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results